Paul M. Sondel

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

Recognition by Human V _γ 9/V _δ 2 T Cells of a GroEL Homolog on Daudi Burkitt's Lymphoma Cells

Paul Fisch, Miroslav Malkovský, Susan Kovats et al. · Science · 1990 · 357 citations

Life Sciences, Immunology, Molecular Biology +17

Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

Rajen Mody, Arlene Naranjo, Collin Van Ryn et al. · The Lancet Oncology · 2017 · 273 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.

Alexander L. Rakhmilevich, J. Turner, M J Ford et al. · Proceedings of the National Academy of Sciences · 1996 · 245 citations

Medicine, Cancer Biology, Oncology +17

Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

Suzanne Shusterman, Wendy B. London, Stephen D. Gillies et al. · Journal of Clinical Oncology · 2010 · 242 citations · Full text

Medicine, Oncology, Pharmacology +13